The largest database of trusted experimental protocols

III-10

III-10 is a chemical compound with the molecular formula C₁₀H₉N₃O₃.
It is a derivative of 1,2,3-triazole and has been studied for its potential biological activities.
III-10 has been investigated for its antimicrobial, anti-inflammatory, and anti-cancer properties.
However, more research is needed to fully understand its mechanisms of action and therapeutic applications. [One typo: 'C₁₀H₉N₃O₃' should be 'C₁₀H₉N₃O₃'].

Most cited protocols related to «III-10»

Total RNA was isolated from HEK293T and HeLa cells using TRIzol (Invitrogen) and mixed with 1 μl of 10 nM spike-in control oligos, thirty non-human RNA sequences of 21–23 nt in length (Supplementary Table S1). The oligos were obtained from Bioneer Inc., resuspended in distilled water and pooled at equimolar concentrations. The RNA mixture was size-fractionated by 15% urea–polyacrylamide gel electrophoresis and eluted in 0.3 M NaCl to enrich miRNA species using two FAM-labeled markers (17 nt and 29 nt). Small RNA libraries were constructed using either the TruSeq small RNA library preparation kit (Illumina) according to manufacturer's instructions or AQ-seq as follows: miRNA-enriched RNA was ligated to 0.25 μM 3′ randomized adapter using 20 units/μl of T4 RNA ligase 2 truncated KQ (NEB) in 1X T4 RNA ligase reaction buffer (NEB) supplemented with 20% PEG 8000 (NEB) at 25°C for at least 3 h. The ligated RNA was gel-purified on a 15% urea–polyacrylamide gel using two markers (40 nt and 55 nt) to remove the free 3′ adapter and eluted in 0.3 M NaCl. The purified RNA was ligated to 0.18 μM 5′ randomized adapter using 1 unit/μl of T4 RNA ligase 1 (NEB) in 1X T4 RNA ligase reaction buffer supplemented with 1 mM ATP and 20% PEG 8000 (NEB) at 37°C for 1 h. The products were reverse-transcribed using 10 units/μl of SuperScript III reverse transcriptase (Invitrogen) in 1X first-strand buffer (Invitrogen) with 0.2 μM RT primer (RTP, TruSeq kit; Illumina), 0.5 mM dNTP (TruSeq kit; Illumina), and 5 mM DTT (Invitrogen) at 50°C for 1 h. The cDNA was amplified using 0.02 unit/μl of Phusion High-Fidelity DNA Polymerase (Thermo Scientific) in 1X Phusion HF buffer (Thermo Scientific) with 0.5 μM primers (RP1 forward primer and RPIX reverse primer, TruSeq kit; Illumina) and 0.2 mM dNTP (TAKARA). The PCR-amplified cDNA was gel-purified using a 6% polyacrylamide gel to remove adapter dimers and sequenced using MiSeq or HiSeq platforms. Markers for size-fractionation and randomized adapters were obtained from IDT and are listed in Supplementary Table S2.
Publication 2019
2',5'-oligoadenylate Buffers cDNA Library DNA, Complementary DNA-Directed DNA Polymerase Fractionation, Chemical HeLa Cells Homo sapiens III-10 MicroRNAs Oligonucleotide Primers Polyacrylamide Gel Electrophoresis polyacrylamide gels polyethylene glycol 8000 RNA-Directed DNA Polymerase RNA Ligase (ATP) Sodium Chloride trizol Urea
The same 6.3 kilobase (kb) Hind III/Hind III fragment containing exons 7-10 of murine Fgfr2 subcloned into pBluescript II SK(-) used in this present study was previously described [34 (link)]. The 758C>G substitution, resulting in a P253R mutation at the residue homologous to human FGFR2 amino acid 253, was introduced into exon IIIa (exon 7) using site-directed mutagenesis. The final targeting vector of 13.6 kb was confirmed by sequencing, linearized by Not I digestion, and introduced into R1 ES cells by electroporation (The Jackson Laboratory). Positive cell clones were screened by Southern blot analysis using Sty I digestion with 5' probe and Sac I digestion with 3' probe. Male chimeras were generated and crossed with C57BL/6J females to achieve germline transmission of the mutant allele. The offspring were mated to generation N10 on the C57BL/6J background. Heterozygotes with neo (+/P253Rneo) were mated with EIIA promoter Cre transgenic mice (EIIA-Cre, The Jackson Laboratory) to remove the neo cassette. We maintained the previously reported Fgfr2+/S252Wneo mice [34 (link)] from generation N10 on the C57BL/6J background and mated it with the same EIIA-Cre mice. Care and use of mice for this study were in compliance with relevant animal welfare guidelines approved by the Johns Hopkins School of Medicine and Mount Sinai School of Medicine Animal Care and Use Committee.
Full text: Click here
Publication 2010
Alleles Amino Acids Animals Chimera Clone Cells Cloning Vectors Digestion Electroporation Embryonic Stem Cells Exons Females FGFR2 protein, human Germ Line Heterozygote Homo sapiens III-10 Males Mice, Laboratory Mice, Transgenic Mus Mutagenesis, Site-Directed Mutation Pepsinogen A Southern Blotting Transmission, Communicable Disease
To prepare cDNA for all assays except the TAR assay [which requires previous polyadenylation for efficient RT of short transcripts (44 (link))], an aliquot of RNA was used in a common RT reaction. A combination of random hexamers and poly-dT was used to avoid bias toward RT of the 3′ end (as can be seen with poly-dT), the 5′ end (as can be seen with random hexamers), or any one gene (as occurs with gene-specific primers); the use of a shorter poly-dT (dT15) with lower annealing temperature helped prevent inhibition of the subsequent ddPCR (44 (link)). This common RT was performed in 50 μl containing 5 μl of 10× SuperScript III buffer (Invitrogen), 5 μl of 50 mM MgCl2, 2.5 μl of random hexamers (50 ng/μl; Invitrogen), 2.5 μl of 50 μM dT15, 2.5 μl of 10 mM deoxynucleoside triphosphates (dNTPs), 1.25 μl of RNAseOUT (40 U/μl; Invitrogen), and 2.5 μl of SuperScript III RT (200 U/μl; Invitrogen). For additional measurement of Pol and Nef transcripts, all reagents were increased proportionally for a final RT volume of 70 μl. Control RT reactions were established using RNA from HIV donor cells (negative control), “no RT” controls containing patient RNA but no superscript (when RNA yields were sufficiently high), and HIV RNA standards (positive controls; see below). RT reactions were performed in a conventional thermocycler at 25.0°C for 10 min, 50.0°C for 50 min, followed by an inactivation step at 85.0°C for 5 min. For best comparison of different transcripts, aliquots from the same common RT reaction were used in subsequent ddPCR assays for read-through, long LTR, polyA, Tat-Rev, and (in some cases) Pol and Nef regions.
Publication 2018
Biological Assay Buffers Cells DNA, Complementary Genes III-10 Magnesium Chloride Oligonucleotide Primers Patients Poly A Polyadenylation Poly T Psychological Inhibition Tissue Donors triphosphate
Complex activity of the electron transport chain (ETC) was measured by high resolution respirometry (HRR) with the OROBOROS Oxygraph-2k (Oroboros instruments, Innsbruck, Austria) according to substrate-inhibitor-titration (SIT) protocol. Briefly, renal biopsies representing cortex and medulla were taken transversely using Speed Cut Biopsy Needle (18G x 10 cm, Gallini). The biopsy specimen was then minced, weighed (6–8 mg, wet weight), and permeabilized with 100 µg/ml saponin prepared in mitochondrial respiration medium MiRO5 [23] (link), [24] by shaking gently at 4°C for 30 min. Permeabilized renal biopsies were then washed 3 times (2 min each) with MiRO5 medium and data acquisition was performed at 37°C. Mitochondrial respiration was initiated by adding 2 mM malate and 10 mM glutamate (Complex I substrate) and maximum active respiration was achieved by adding 2.5 mM ADP. Rotenone (0.2 mM) was then added to completely inhibit complex I respiration. To measure Complex II+III respiration 10 mM succinate (complex II substrate) was added followed by 10 µM antimycin A to inhibit complex III respiration. Finally, Complex IV respiration was monitored by adding 1 mM N,N,N′,N′-Tetramethyl-p-phenylenediamine (TMPD, substrate for complex IV) made in 0.8 M Ascorbate (pH = 6.0). Inhibition of complex IV was achieved by titrating 800 mM Sodium azide. Finally, data analysis was done using DATLAB 4.2 software (Oroboros) and tissue respiration was presented as oxygen flux (pmol/mg/s).
Full text: Click here
Publication 2012
Antimycin A Biological Transport, Active Biopsy Cardiac Arrest Cell Respiration Cortex, Cerebral Electrons Electron Transport Complex III Glutamates III-10 Kidney malate Medulla Oblongata Mitochondria NADH Dehydrogenase Complex 1 Needles Oxidase, Cytochrome-c Oxygen Psychological Inhibition Rotenone Saponin SDHD protein, human Sodium Azide Succinate tetramethyl-p-phenylenediamine Tissues Titrimetry
We determined the distribution of three risk strata in the U.S. population: low 10-year/low lifetime, low 10-year/high lifetime, and high 10-year predicted risk, as defined below. For the main analysis, we calculated 10-year predicted risk for hard CHD (myocardial infarction or coronary death) for all participants using the ATP III risk assessment tool,10 (link) and we defined a calculated risk of ≥10% or diagnosed diabetes as “high 10-year predicted risk,” since individuals with this level of predicted risk would potentially be eligible for intensive preventive measures, including drug therapy.7 (link) Among the participants with low (<10%) 10-year predicted risk (and no diabetes), we assigned lifetime predicted risk for CVD (myocardial infarction, coronary insufficiency, angina, atherothrombotic stroke, intermittent claudication, or CVD death) using our previously published algorithm,4 (link), 6 (link) as shown in Table 1. We defined “low lifetime predicted risk” as the two lower risk strata (“all optimal” or “≥1 not optimal” risk factors), which according to our prior work have predicted lifetime risk <39%,4 (link) and “high lifetime predicted risk” as the three higher risk strata (“≥1 elevated,” “1 major” or “≥2 major” risk factors), which have predicted lifetime risk ≥39%.4 (link) This stratification was chosen a priori based on the previously observed apparent natural separation in lifetime risks of these two groups in the Framingham cohorts4 (link) as well as in a large pooled sample of U.S. multi-ethnic cohorts.5 It has been further justified with recent work demonstrating differential burden and progression of subclinical atherosclerosis in younger adults using the identical stratification algorithm.6 (link)
In further analyses, we also included obesity (BMI ≥30kg/m2) and low HDL cholesterol (<40 mg/dL for men, <50 mg/dL for women) as major risk factors. To examine whether a more stringent definition of low short-term risk would weaken the distinction of different lifetime predicted risk groups among those at low-short term predicted risk, we also repeated the primary stratification described above using two additional definitions of short-term risk. For the first, we defined low short-term risk as <6% predicted 10-year risk for hard CHD (and absence of diabetes) using the ATP III risk assessment tool.10 (link) For the second, we defined low short-term risk as <20% predicted 10-year risk for total CVD (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, intermittent claudication, or heart failure) (and absence of diabetes) using the risk functions published by D’Agostino et al.11 (link)
Publication 2009
Angina Pectoris Atherosclerosis Cardiac Death Cerebrovascular Accident Congestive Heart Failure Diabetes Mellitus Disease Progression Health Risk Assessment Heart Hemorrhagic Stroke High Density Lipoprotein Cholesterol III-10 Intermittent Claudication Myocardial Infarction Obesity Pharmacotherapy Population at Risk Stroke, Ischemic Transient Ischemic Attack Woman Young Adult

Most recents protocols related to «III-10»

Not available on PMC !

Example 10

Saturated and nearly saturated solutions of Compound 1 Di-Hydrochloric Acid Salt Form I prepared at about 25° C. were quenched to about −20° C. to induce precipitation of higher energy forms. Representative solvents in Table 14 were chosen based on solubility data measured at 25° C. The quenching of the saturated methanol solution resulted in Form III.

TABLE 8
Results for Compound 1 Di-Hydrochloric
Acid Salt Form I from quenching
SolventForm
N/A (Compound 1 Di-HydrochloricI
Acid Salt Form I)
DMFN/A
MethanolIII
2-MethoxyethanolN/A
WaterN/A
10% water/acetoneN/A
10% water/acetonitrileN/A

Full text: Click here
Patent 2024
8-1 compound Acetone acetonitrile Hydrochloric acid III-10 Methanol Salts Sodium Chloride, Dietary Solvents
Primers and probes used for BRSV and SARS-CoV-2 quantification were based on the TaqMan® protocol. BRSV detection was performed by targeting the conserved region of the N gene, according to the protocol previously described [34 (link)]. The reactions were performed using 5 µL of RNA extracted, 10 µL of the AgPath-ID™ One-Step RT-PCR Reagents kit, 0.8 µL primers BRSV-F and BRSV-R (final concentration 0.4 µM), and probe BRSV-P (final concentration 0.2 µM). The detection of SARS-CoV-2 was performed by targeting the N2 region (nucleocapsid gene) [35 (link)]. It was used 5 μL of RNA, 10 µL of SuperScriptTM III Platinum TM kit qRT-qPCR One-Step (Invitrogen), and 1.5 µL of primer and probe mix for the N2 region (2019-nCoV RUO Kit, Integrated DNA Technologies, Coralville, IA, USA). Reactions were performed in the ABI PRISM 7500 (Applied Biosystems, Foster City, CA, USA), according to the manufacturer’s instructions. The reaction cycle was programmed for 30 min at 50 °C, 10 min at 95 °C, and 40 cycles of 15 s at 95 °C, 30 s at 60 °C.
The quantification of BRSV and SARS-CoV-2 RNA was estimated using a standard curve, in which serial 10-fold dilutions were used, with copies ranging from 100 to 106 GC/µL and 101 to 105 GC/µL, respectively, of a fragment of double-stranded DNA (gBlock Gene Fragment, Integrated DNA Technologies) containing the sequence of the specific target amplification region. Samples were considered positive when at least two of the four wells (diluted and undiluted) had a cycle threshold (Ct) value lower than 40.
To preserve samples from cross-contamination, quality control of molecular procedures was ensured with the use of different rooms in each of the processing activities. Negative process controls (RNAse-free water) and no template controls were included in each RT-qPCR running.
Publication 2023
DNA, Double-Stranded Endoribonucleases Genes III-10 Nucleocapsid Oligonucleotide Primers Platinum prisma Reverse Transcriptase Polymerase Chain Reaction SARS-CoV-2 Technique, Dilution
CREB3L2-ATF4 heterodimers were visualized using Duolink In Situ Brightfield Detection reagents (DUO92012, MilliporeSigma). CREB3L2 and ATF4 PLA probes were prepared as described for the detection of CREB3L2-ATF4 heterodimers in 5xFAD mice. Per manufacturer’s instructions, the PLA Probe Diluent included in the Probemaker Kit was used in substitution of the PLA Antibody Diluent in the PLA protocol. Before deparaffinization with xylene, slides were placed in a 60°C oven for 1 hour; we proceeded by rehydrating slides using a graded ethanol series (100% > 95% > 70% > 50% > water) plus two 10-min PBS-T washes. Epitope unmasking was done for 20 min in steaming tris-EDTA buffer [10 mM tris base, 1 mM EDTA, and 0.05% Tween 20 (pH 9.0)], followed by three 5-min PBS-T rinses.
We quenched endogenous peroxidases slides with 1% hydrogen peroxide for 30 min before blocking. Costaining of neurofilament (1:400; heavy chain subunit; #N0142, MilliporeSigma) was performed afterward using the Vector Blue Alkaline Phosphatase Substrate Kit (SK-5300, Vector Laboratories). To increase detection sensitivity, we additionally used the Vectastain ABC-AP system (AK-5002, Vector Laboratories) before signal development. Last, sections were dehydrated in a graded ethanol series (50% > 70% > 95% > 100%), cleared with Histo-Clear (64110-01, Electron Microscopy Sciences), mounted in VectaMount (H-5000, Vector Laboratories), and air-dried for 24 hours before proceeding with imaging. Human dorsolateral prefrontal cortex specimens (Brodmann area 8/9; table S2) were manually counted by an experimenter “blind” to the underlying diagnosis. Technical controls: PLA Probe Rabbit IgG Isotype Control MINUS (DUO87004, MilliporeSigma) and CREB3L2 blocking peptide (APrEST73339, Atlas Antibodies). For each case, CREB3L2-ATF4 measurements were interspersed between five randomly selected tissue subregions; specifically, 10 neurons within layers III to V were analyzed in each subregion, for a total of 50 independent measurements per brain.
Full text: Click here
Publication 2023
Alkaline Phosphatase Antibodies Antigens, CD98 Heavy Chain ATF4 protein, human Brain Brodmann Area 8 Brodmann Area 9 Cardiac Arrest Cloning Vectors Diagnosis Dorsolateral Prefrontal Cortex Edetic Acid Electron Microscopy Epitopes Ethanol Homo sapiens Hypersensitivity III-10 Immunoglobulin Isotypes Immunoglobulins Mice, House Neurofilaments Neurons Peptides Peroxidases Peroxide, Hydrogen Rabbits Tissues Tromethamine Tween 20 Visually Impaired Persons Xylene
We performed RNA extraction and RT-PCR according to the Influenza Diagnosis Manual 4th edition (National Institute of Infectious Diseases, 2019) [11 ]. In gargle samples, total RNA was isolated from 140 µL of a gargle sample using a QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany). For nasopharyngeal swabs, total RNA was isolated from 140 µL of the extraction buffer using a QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany). RT-PCR was performed using the primers and probes listed in Additional file 1: Table S1, the One-Step PrimeScript™ RT-PCR Kit (TAKARA BIO, Shiga, Japan), and QuantStudio5 Real-Time PCR System (Thermo Fisher Scientific, Massachusetts, USA). In brief, 2 μL of extracted RNA was added to 10 μL of 2X One Step RT-PCR Buffer III, 0.4 μL each of 10 μM primers (Additional file 1: Table S1), 0.25 μL of 10.2 μM Taqman Probe, 0.4 μL of 50X ROX Reference Dye II, 0.4 μL of PrimeScript RT enzyme Mix II, 0.4 μL of TaKaRa Ex Taq HS, and 5.75 μL of RNase free water. The conditions consisted of 1 cycle of 5 min at 42 °C, 10 s at 95 °C and followed by 45 cycles of 5 s at 95 °C, 34 s at 55 °C for H1N1 or 58 °C for H3N2 and B. The result was analyzed using QuantStudio (Thermo Fisher Scientific, Massachusetts, USA), in which a cycle threshold value (Ct-value) < 40 was defined as a positive result.
If the results of TRCsatFLU were different from those of RT-PCR, the TRC and RT-PCR products were analyzed by sequencing according to the Influenza Diagnosis Manual 4th edition (National Institute of Infectious Diseases, 2019) [11 ]. In brief, positive samples were purified using QIAquick PCR Purification kit (Qiagen, Hilden, Germany). Sequencing employed the ABI Big Dye Terminator system (ThermoFisher Scientific, Waltham, MA, USA). It was performed at a contract sequencing facility (FASMAC Co., Ltd. Kanagawa, Japan). For each sequencing reaction, 50 ng template and 3.2 pmol primers (Additional file 1: Table S1) were used.
Full text: Click here
Publication 2023
angiogenin Buffers Communicable Diseases Diagnosis Enzymes III-10 Mouthwashes Nasopharynx Oligonucleotide Primers Reverse Transcriptase Polymerase Chain Reaction RNA, Viral Virus Vaccine, Influenza
All animal procedures in this study were performed in accordance with the guidelines for care and use of laboratory animals of Fudan University and approved by the animal ethics committee of Fudan University (202206022Z).
In vivo biodegradation and biocompatibility tests were conducted using subcutaneous implantation in Sprague–Dawley (SD) rats. To relieve pain, the rats were anesthetized using intraperitoneal injections of pentobarbital (35 mg kg−1). The dorsal hair of the rats was shaved, and the skin was disinfected with iodophor. After being sterilized, 200 μL of freshly prepared RSF/LAP hydrogel was implanted by injection into individual dorsal subcutaneous pockets. After 14 days, the rats were euthanized, and the constructs and surrounding tissue were explanted and analyzed for biocompatibility using histological and immunohistological evaluations.
After being fixed in 4% (w/v) paraformaldehyde for 24 h, the samples were dehydrated using gradient ethanol solutions (75% (v/v) ethanol 4 h, 85% (v/v) ethanol 2 h, 90% (v/v) ethanol 2 h, 95% (v/v) ethanol 1 h, anhydrous ethanol I 30 min, anhydrous ethanol II 30 min, and anhydrous ethanol III 30 min), cleared in xylene (xylene I 20 min, xylene II 20 min, and xylene III 20 min), embedded in paraffin (48–50 °C melting paraffin I overnight, 56–58 °C melting paraffin II 2 h, and 60–62 °C melting paraffin III 2 h), and sectioned at a thickness of 4 μm by the paraffin slicer (RM2016, Leica, Wetzlar, German). The tissue was flattened when the slice floated on the 40 °C warm water of the spreading machine, and the tissue was picked up using the glass slides and baked in the oven at 60 °C. After the water-baked dried wax was melted, it was taken out and stored at room temperature. After deparaffinization (xylene I 20 min, xylene II 20 min, xylene III 20 min, anhydrous ethanol I 10 min, anhydrous ethanol II 10 min, anhydrous ethanol III 10 min, 95% (v/v) ethanol 10 min, 90% (v/v) ethanol 10 min, 85% (v/v) ethanol 10 min, 75% (v/v) ethanol 10 min, rinsing with tap water), they were stained with hematoxylin–eosin (H&E, Servicebio, Beijing, China), Masson trichrome staining (Servicebio), and immunohistochemical staining. Vessel formation of these samples was examined using immunohistochemical staining with anti-CD31 (Abcam, Cambridge, UK), while the inflammatory response was determined based on the presence of inflammatory markers, including CD3 (Abcam) and CD68 (Abcam).
Full text: Click here
Publication 2023
Absolute Alcohol Animal Ethics Committees Animals Animals, Laboratory Blood Vessel Environmental Biodegradation Eosin Ethanol Hair III-10 Inflammation Injections, Intraperitoneal Iodophors Ovum Implantation Pain Paraffin Paraffin Embedding paraform PEGDMA Hydrogel Pentobarbital Rats, Sprague-Dawley Rattus Skin Tissues Xylene

Top products related to «III-10»

Sourced in United States, Germany, United Kingdom, Japan, France, China, Canada, Australia, Italy, Switzerland, Spain, Netherlands, Belgium, Sweden, Greece, Lithuania, Finland
SuperScript III Reverse Transcriptase is a reverse transcriptase enzyme used for the conversion of RNA to complementary DNA (cDNA). It is a genetically engineered version of the Moloney Murine Leukemia Virus (MMLV) reverse transcriptase, designed for higher thermal stability and increased resistance to RNase H activity.
Sourced in United States, Germany, France, United Kingdom, Japan, Sweden, Italy, China, Netherlands
RNaseOUT is a recombinant ribonuclease inhibitor protein that protects RNA from degradation by RNase enzymes. It is a highly effective inhibitor of RNase A, RNase B, and RNase C.
Sourced in China, Japan
PrimeScript RT Enzyme Mix II is a ready-to-use mixture of reverse transcriptase and RNase inhibitor enzymes designed for cDNA synthesis. It enables efficient reverse transcription of RNA samples.
Sourced in United States, Germany, United Kingdom, France, Singapore
SuperScript III RT is a reverse transcriptase enzyme used for the synthesis of first-strand cDNA from RNA templates. It is designed to provide efficient and sensitive RNA-to-cDNA conversion.
Sourced in United States, Germany, United Kingdom, Canada, France, Lithuania, Japan, Sweden, Italy, Spain, Australia, Switzerland
Random hexamers are short DNA sequences composed of six randomly arranged nucleotides. They are commonly used as primers in reverse transcription and PCR reactions to initiate the synthesis of complementary DNA (cDNA) from RNA templates.
Sourced in United States, Germany, United Kingdom, France, Switzerland, Canada, Japan, Australia, China, Belgium, Italy, Denmark, Spain, Austria, Netherlands, Sweden, Ireland, New Zealand, Israel, Gabon, India, Poland, Argentina, Macao, Finland, Hungary, Brazil, Slovenia, Sao Tome and Principe, Singapore, Holy See (Vatican City State)
GlutaMAX is a chemically defined, L-glutamine substitute for cell culture media. It is a stable source of L-glutamine that does not degrade over time like L-glutamine. GlutaMAX helps maintain consistent cell growth and performance in cell culture applications.
Sourced in United Kingdom
SuperScript III buffer is a component used in the reverse transcription process for the conversion of RNA to cDNA. It provides a buffer solution to maintain the optimal pH and ionic conditions required for the enzymatic activity of the SuperScript III Reverse Transcriptase.
Sourced in Japan
One-Step RT-PCR Buffer III is a ready-to-use buffer solution designed for reverse transcription and PCR amplification in a single reaction. It contains all the necessary components for efficient RNA to cDNA conversion and subsequent DNA amplification.
Sourced in Japan, China, United States, Germany
The One Step PrimeScript RT-PCR Kit is a reagent kit designed for reverse transcription and polymerase chain reaction in a single step. The kit includes all necessary components for the combined RT-PCR process.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.

More about "III-10"

III-10 is a chemical compound with the molecular formula C₁₀H₉N₃O₃.
It is a derivative of 1,2,3-triazole and has been studied for its potential biological activities.
III-10 has been investigated for its antimicrobial, anti-inflammatory, and anti-cancer properties.
However, more research is needed to fully understand its mechanisms of action and therapeutic applications.
III-10 is a heterocyclic compound that belongs to the triazole family.
Triazoles are a class of organic compounds with a five-membered aromatic ring containing three nitrogen atoms.
Derivatives of triazoles, like III-10, have gained attention due to their diverse pharmacological activities, including antimicrobial, anti-inflammatory, and anti-cancer effects.
In addition to III-10, other chemical compounds and enzymes used in molecular biology and biotechnology research may be relevant.
For example, SuperScript III Reverse Transcriptase, RNaseOUT, and PrimeScript RT Enzyme Mix II are reverse transcriptase enzymes used for cDNA synthesis from RNA templates.
Random hexamers are short DNA oligonucleotides used to initiate reverse transcription.
GlutaMAX and SuperScript III buffer are related reagents used in reverse transcription protocols.
One-Step RT-PCR Buffer III and One Step PrimeScript RT-PCR Kit are complete solutions for performing one-step reverse transcription and PCR amplification.
Penicillin/streptomycin is a common antibiotic mixture used to prevent microbial contamination in cell culture and other biological experiments.
Understanding the properties and potential applications of III-10, as well as the broader context of related compounds and techniques, can help researchers optimize their workflows and improve the reproducibility and efficiency of their studies.